FDA’s Gottlieb heads back to AEI to tackle drug prices

Scott Gottlieb, the FDA commissioner who will step down Friday, plans to return to the American Enterprise Institute to write about and research drug prices.

Source: Washington Post: To Your Health - April 4, 2019 Category: Consumer Health News Authors: Laurie McGinley Source Type: news